DZNE is a research institute for neurodegenerative diseases such as Alzheimer’s, Parkinson’s and ALS, which are associated with dementia, movement disorders and other serious health impairments. To date, there are no cures for these diseases, which represent an enormous burden for countless patients, their families and the healthcare system. DZNE is dedicated to the development and translation into practice of novel strategies for prevention, diagnosis, care and treatment. The institute comprises ten sites across Germany and collaborates with universities, university hospitals, research centers and other institutions in Germany and throughout the world.
The European Medicines Agency (EMA) has now given the green light for the antibody lecanemab. This means that the first causal agent for Alzheimer's disease is on the verge of approval in the EU. We…
What opportunities will arise for medical research and the healthcare system of the future? To discuss this question, researchers from the Helmholtz Association met with decision-makers from science,…
Alzheimer’s dementia is one of the greatest challenges in neurodegeneration. Significant progress in early detection is being advanced at the German Center for Neurodegenerative Diseases (DZNE) in…
What does an artificial intelligence (AI) model look like that can answer a wide variety of medical questions using radiological image data? The Human Radiome Project aims to set the gold standard.
Neurologist and neuroscientist Gabor Petzold of the German Center for Neurodegenerative Diseases (DZNE) criticizes the decision of the European Medicines Agency (EMA) not to approve the novel…
Cancer, dementia, diabetes: Eating a healthy diet can prevent numerous diseases. Yet many people still underestimate the importance of food for prevention. Helmholtz researchers provide arguments for…
Contact
Deutsches Zentrum für Neurodegenerative Erkrankungen
